title: Quality Control of Insulins and Biosimilar Insulins: What Do We Know?
authors.affiliation: MRIGlobal, Kansas City, MO, USA University of Missouri-Kansas City, Kansas City, MO, USA acarter@mriglobal.org.
authors.forename: Alan W
authors.initials: AW
authors.lastname: Carter
authors.affiliation: Science & Co., Düsseldorf, Germany.
authors.forename: Lutz
authors.initials: L
authors.lastname: Heinemann
authors.forename: David C
authors.initials: DC
authors.lastname: Klonoff
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000592:standards*; D004345:Drug Industry / Q000592:standards; D006801:Humans; D007004:Hypoglycemic Agents / Q000592:standards*; D007328:Insulin / Q000592:standards*; D011786:Quality Control
chemical_list: D059451:Biosimilar Pharmaceuticals; D007004:Hypoglycemic Agents; D007328:Insulin
keywords: biosimilar insulin; insulin; quality; therapy